Upload
Featured Recent Articles Topics Login Upload

Search Results for 'major bleeding'

major bleeding published presentations and documents on DocSlides.

Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet trea
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet trea
by ThoughtfulTiger
Presenter: . Meng-Jiun. . Chiou. 5Sep2017. 1. Int...
Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-
Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-
by melanie
Provided by ProCE, LLC and supported by an educati...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Stroke, Bleeding, and
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
Update in the Perioperative and Emergency Management of Nov
Update in the Perioperative and Emergency Management of Nov
by danika-pritchard
Annelise Gallien, MD FRCPC. Moncton City Hospital...
Two-Year Outcomes of
Two-Year Outcomes of
by jane-oiler
High Bleeding Risk Patients after Polymer-Free Dr...
Bivalirudin with Provisional GPIIb/IIIa Inhibition – the
Bivalirudin with Provisional GPIIb/IIIa Inhibition – the
by myesha-ticknor
Gregg W. Stone MD. Columbia University Medical Ce...
Concomitant Antiplatelet and OAC
Concomitant Antiplatelet and OAC
by kittie-lecroy
Tx. : . Real-World Practice. In the US, ~800,000 ...
Skill Section:
Skill Section:
by trish-goza
Wilderness. First Aid. Skill . 3. /17. :. Minor ...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
EINSTEIN DVT and EINSTEIN PE Pooled Analysis
EINSTEIN DVT and EINSTEIN PE Pooled Analysis
by olivia-moreira
'Xarelto' for the Treatment of Symptomatic Venous...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Wounds
Wounds
by cheryl-pisano
Wounds. A wound. . is an injury that damages the...
The EINSTEIN EXT Study 'Xarelto' for
The EINSTEIN EXT Study 'Xarelto' for
by tatiana-dople
the . Long-Term Prevention of Recurrent Venous Th...
The EINSTEIN PE Study 'Xarelto' for the Acute and Continued Treatment of Symptomatic Pulmonary Embo
The EINSTEIN PE Study 'Xarelto' for the Acute and Continued Treatment of Symptomatic Pulmonary Embo
by marina-yarberry
Effective PE Treatment Matters. PE is a potential...
Updates in Anticoagulation:
Updates in Anticoagulation:
by test
What Did We Learn From ESC 2017?. COMPASS: . Tria...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by cheryl-pisano
Announcements. Thank you attending the ACCP Cardi...
Antithrombotic Therapy Taylor B Goot MD
Antithrombotic Therapy Taylor B Goot MD
by cheryl-pisano
Assistant Professor. Department of Internal Medic...
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
by tatiana-dople
www.onlinecjc.com. ). .  . If your reuse request...
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
by dsuser1
Christopher Granger, . MD. Sean Pokorney, MD. . D...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
Review on NOACs Studies Dr.
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
x0000x0000 For more information call 18553547847 1855
x0000x0000 For more information call 18553547847 1855
by eddey
�� Call your doctor or health...
Guidance for the use of Blood Components
Guidance for the use of Blood Components
by gagnon
This guidance is based on the National Blood Trans...
29 th 2022, Hot Line Session 9
29 th 2022, Hot Line Session 9
by yvonne
Giuseppe Gargiulo, MD, PhD. University Federico II...
Adult major haemorrhage protocol (MHP)
Adult major haemorrhage protocol (MHP)
by payton
template. * . An MHP includes a multidisciplinary ...
Tranexamic acid in patients undergoing noncardiac surgery
Tranexamic acid in patients undergoing noncardiac surgery
by yael856
Dr. PJ Devereaux on behalf of POISE-3. Investigat...
New Oral Anticoagulants: A Review
New Oral Anticoagulants: A Review
by phoebe-click
Babak Moini, MD. Veterans Affairs Hospital. Noon ...
Selecting Direct Oral Anticoagulants and Reversal Agents
Selecting Direct Oral Anticoagulants and Reversal Agents
by tremblay
Geno J . Merli. , MD, MACP, FSVM, FHM. Professor M...
Updates in Anticoagulation:
Updates in Anticoagulation:
by alida-meadow
Key Sessions at ESC 2017. COMPASS: . Trial Design...
Rivaroxaban in stable peripheral or carotid artery disease
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
COMPASS: Show Us the Way for Medical Management of PAD
COMPASS: Show Us the Way for Medical Management of PAD
by miller
Clinical Associate Professor of Medicine. SSM Heal...
Factor Eight Inhibitor Bypassing Activity (FEIBA) for the R
Factor Eight Inhibitor Bypassing Activity (FEIBA) for the R
by jane-oiler
Warfarin. Induced . Coagulopathy. : A Pilot Stud...
Anticoagulation Reversal
Anticoagulation Reversal
by test
May 11, 2013. Objectives. Develop an approach for...
Perioperative
Perioperative
by pasty-toler
Aspirin & . POISE-2. Neal Gerstein, MD FASE. ...
Rivaroxaban compared with enoxaparin for the prevention of
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...
Aspirin for Preventing the Recurrence of Venous
Aspirin for Preventing the Recurrence of Venous
by liane-varnes
Thromboembolism. N . Engl. J Med. 2012;366:1959-...
ANTICOAGULATION Blake Wachter
ANTICOAGULATION Blake Wachter
by olivia-moreira
, MD, PhD . Monday Morning Conference. Oct 4, 201...
Dabigatran in myocardial injury after noncardiac
Dabigatran in myocardial injury after noncardiac
by lois-ondreau
surgery. Dr. PJ Devereaux on behalf of . MANAGE I...
A New Era for NOACs: Program Goals
A New Era for NOACs: Program Goals
by danika-pritchard
Evidence For NOACs in Patients With NVAF-PCI. PIO...